{
    "relation": [
        [
            "Feature key",
            "Describes the sequence of naturally occurring alternative protein isoform(s). The changes in the amino acid sequence may be due to alternative splicing, alternative promoter usage, alternative initiation, or ribosomal frameshifting. The information stored in this subsection is used to automatically construct alternative protein sequence(s) for display.More...Alternative sequencei",
            "Describes the sequence of naturally occurring alternative protein isoform(s). The changes in the amino acid sequence may be due to alternative splicing, alternative promoter usage, alternative initiation, or ribosomal frameshifting. The information stored in this subsection is used to automatically construct alternative protein sequence(s) for display.More...Alternative sequencei",
            "Describes the sequence of naturally occurring alternative protein isoform(s). The changes in the amino acid sequence may be due to alternative splicing, alternative promoter usage, alternative initiation, or ribosomal frameshifting. The information stored in this subsection is used to automatically construct alternative protein sequence(s) for display.More...Alternative sequencei",
            "Describes the sequence of naturally occurring alternative protein isoform(s). The changes in the amino acid sequence may be due to alternative splicing, alternative promoter usage, alternative initiation, or ribosomal frameshifting. The information stored in this subsection is used to automatically construct alternative protein sequence(s) for display.More...Alternative sequencei",
            "Describes the sequence of naturally occurring alternative protein isoform(s). The changes in the amino acid sequence may be due to alternative splicing, alternative promoter usage, alternative initiation, or ribosomal frameshifting. The information stored in this subsection is used to automatically construct alternative protein sequence(s) for display.More...Alternative sequencei",
            "Describes the sequence of naturally occurring alternative protein isoform(s). The changes in the amino acid sequence may be due to alternative splicing, alternative promoter usage, alternative initiation, or ribosomal frameshifting. The information stored in this subsection is used to automatically construct alternative protein sequence(s) for display.More...Alternative sequencei",
            "Describes the sequence of naturally occurring alternative protein isoform(s). The changes in the amino acid sequence may be due to alternative splicing, alternative promoter usage, alternative initiation, or ribosomal frameshifting. The information stored in this subsection is used to automatically construct alternative protein sequence(s) for display.More...Alternative sequencei",
            "Describes the sequence of naturally occurring alternative protein isoform(s). The changes in the amino acid sequence may be due to alternative splicing, alternative promoter usage, alternative initiation, or ribosomal frameshifting. The information stored in this subsection is used to automatically construct alternative protein sequence(s) for display.More...Alternative sequencei"
        ],
        [
            "Position(s)",
            "411 \u2013 516",
            "475 \u2013 495",
            "496 \u2013 1400",
            "628 \u2013 647",
            "648 \u2013 1400",
            "884 \u2013 932",
            "884 \u2013 907",
            "908 \u2013 1400"
        ],
        [
            "Length",
            "106",
            "21",
            "905",
            "20",
            "753",
            "49",
            "24",
            "493"
        ],
        [
            "Description",
            "Missing in isoform RON-2. 1 Publication Manually curated information that is based on statements in scientific articles for which there is no experimental support. More\u2026 Manual assertion based on opinion ini Ref.3 \"Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis.\" Jin P., Zhang J., Sumariwalla P.F., Ni I., Jorgensen B., Crawford D., Phillips S., Feldmann M., Shepard H.M., Paleolog E.M. Arthritis Res. Ther. 10:R73-R73(2008) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS RON-1; RON-2; RON-3 AND RON-4).",
            "ELVRS\u2026LGDSG \u2192 GPHPHSPLALGPCLHPHFAH I in isoform RON-1. 1 Publication Manually curated information that is based on statements in scientific articles for which there is no experimental support. More\u2026 Manual assertion based on opinion ini Ref.3 \"Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis.\" Jin P., Zhang J., Sumariwalla P.F., Ni I., Jorgensen B., Crawford D., Phillips S., Feldmann M., Shepard H.M., Paleolog E.M. Arthritis Res. Ther. 10:R73-R73(2008) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS RON-1; RON-2; RON-3 AND RON-4).",
            "Missing in isoform RON-1. 1 Publication Manually curated information that is based on statements in scientific articles for which there is no experimental support. More\u2026 Manual assertion based on opinion ini Ref.3 \"Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis.\" Jin P., Zhang J., Sumariwalla P.F., Ni I., Jorgensen B., Crawford D., Phillips S., Feldmann M., Shepard H.M., Paleolog E.M. Arthritis Res. Ther. 10:R73-R73(2008) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS RON-1; RON-2; RON-3 AND RON-4).",
            "PVPRK\u2026EPLGT \u2192 YNLVPPLPFPEGGNQAAPSP in isoform RON-2 and isoform RON-4. 1 Publication Manually curated information that is based on statements in scientific articles for which there is no experimental support. More\u2026 Manual assertion based on opinion ini Ref.3 \"Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis.\" Jin P., Zhang J., Sumariwalla P.F., Ni I., Jorgensen B., Crawford D., Phillips S., Feldmann M., Shepard H.M., Paleolog E.M. Arthritis Res. Ther. 10:R73-R73(2008) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS RON-1; RON-2; RON-3 AND RON-4).",
            "Missing in isoform RON-2 and isoform RON-4. 1 Publication Manually curated information that is based on statements in scientific articles for which there is no experimental support. More\u2026 Manual assertion based on opinion ini Ref.3 \"Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis.\" Jin P., Zhang J., Sumariwalla P.F., Ni I., Jorgensen B., Crawford D., Phillips S., Feldmann M., Shepard H.M., Paleolog E.M. Arthritis Res. Ther. 10:R73-R73(2008) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS RON-1; RON-2; RON-3 AND RON-4).",
            "Missing in isoform Delta-RON. Curated",
            "YIGLG\u2026ESCQH \u2192 VSVRDRGRDSWGSESRGQPT GWSS in isoform RON-3. 1 Publication Manually curated information that is based on statements in scientific articles for which there is no experimental support. More\u2026 Manual assertion based on opinion ini Ref.3 \"Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis.\" Jin P., Zhang J., Sumariwalla P.F., Ni I., Jorgensen B., Crawford D., Phillips S., Feldmann M., Shepard H.M., Paleolog E.M. Arthritis Res. Ther. 10:R73-R73(2008) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS RON-1; RON-2; RON-3 AND RON-4).",
            "Missing in isoform RON-3. 1 Publication Manually curated information that is based on statements in scientific articles for which there is no experimental support. More\u2026 Manual assertion based on opinion ini Ref.3 \"Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis.\" Jin P., Zhang J., Sumariwalla P.F., Ni I., Jorgensen B., Crawford D., Phillips S., Feldmann M., Shepard H.M., Paleolog E.M. Arthritis Res. Ther. 10:R73-R73(2008) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS RON-1; RON-2; RON-3 AND RON-4)."
        ],
        [
            "Graphical view",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            ""
        ],
        [
            "Feature identifier",
            "VSP_038919",
            "VSP_038920",
            "VSP_038921",
            "VSP_038922",
            "VSP_038923",
            "VSP_005007",
            "VSP_038924",
            "VSP_038925"
        ],
        [
            "Actions",
            "Add BLAST",
            "Add BLAST",
            "Add BLAST",
            "Add BLAST",
            "Add BLAST",
            "Add BLAST",
            "Add BLAST",
            "Add BLAST"
        ]
    ],
    "pageTitle": "MST1R - Macrophage-stimulating protein receptor precursor - Homo sapiens (Human)",
    "title": "",
    "url": "http://www.uniprot.org/uniprot/Q04912",
    "hasHeader": true,
    "headerPosition": "FIRST_ROW",
    "tableType": "RELATION",
    "tableNum": 25,
    "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042991076.30/warc/CC-MAIN-20150728002311-00155-ip-10-236-191-2.ec2.internal.warc.gz",
    "recordEndOffset": 797781615,
    "recordOffset": 797717150,
    "tableOrientation": "HORIZONTAL",
    "lastModified": "Wed, 22 Jul 2015 00:00:00 GMT",
    "textBeforeTable": "Alternative sequence VAR_041778 Corresponds to variant rs56330223 [ dbSNP | Ensembl ]. VARIANTS [LARGE SCALE ANALYSIS] SER-75; THR-95; CYS-185; GLN-322; ASP-356; LEU-434; ASP-465; CYS-504; ARG-523; PRO-613; MET-900; GLY-1304; GLY-1335 AND CYS-1360. Cited for: Abstract] Europe PMC] [ PubMed] [ Nature 446:153-158(2007) [ Stratton M.R. , Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F., Green A.R.,",
    "textAfterTable": "Sequence databases Select the link destinations: EMBL nucleotide sequence database<br/><a href='/database/22'>More..</a>EMBLi GenBank nucleotide sequence database<br/><a href='/database/28'>More..</a>GenBanki DNA Data Bank of Japan; a nucleotide sequence database<br/><a href='/database/14'>More..</a>DDBJi Links Updated X70040 mRNA. Translation: CAA49634.1. EU826582 mRNA. Translation: ACF47618.1. EU826583 mRNA. Translation: ACF47619.1. EU826584 mRNA. Translation: ACF47620.1. EU826585 mRNA. Translation: ACF47621.1. AC105935 Genomic DNA. No translation available. The Consensus CDS (CCDS) project<br/><a href='/database/187'>More..</a>CCDSi CCDS2807.1. [Q04912-1] CCDS58833.1. [Q04912-2] Protein sequence database of the Protein Information Resource<br/><a href='/database/78'>More..</a>PIRi I38185. NCBI Reference Sequences<br/><a href='/database/117'>More..</a>RefSeqi NP_001231866.1. NM_001244937.1. NP_002438.2.",
    "hasKeyColumn": false,
    "keyColumnIndex": -1,
    "headerRowIndex": 0
}